We've been talking in class about overdominance, or heterozygote advantage. One of the classic examples of overdominance is the case of sickle-cell anemia. A brief synopsis is given
here. Basically, the sickle-cell mutation results in clumped hemoglobin. If you are homozygous for this mutation, you have the disease and have a low probability of survival. However, heterozygotes do not show the disease, and are more resistant to malaria than homozygotes without the sickle-cell allele. Therefore, in malaria-ridden areas, the fittest genotype will be the heterozygote. Because of this fact, we see an equilibrium that maximizes the fitness of the population by balancing the number of heterozygotes with high fitness against the number of homozygous individuals with sickle-cell anemia, resulting in an intermediate frequency of the sickle-cell allele. This is natural selection's solution to the problem, and it isn't an ideal one. Again, natural selection doesn't lead to perfection.
Perhaps we won't have to rely on this cheesy evolutionary fix much longer though, as there is great news on the fight against malaria. A new study of an experimental vaccine has shown that it reduces incidence of malaria in children by about 55%
[STORY]. This is the first vaccine to be used against a eukaryotic parasite. In general, fighting eukaryotic diseases can be tricky. For example, it is often easier to clear a bacterial infection than a fungal infection. Why? Evolutionary principles! Eukaryotes are more closely related to us, so they share more of our molecular machinery. Consequently, it's easy to kill a fungus, but it may be hard to kill a fungus without killing us in the process.